22-Apr-2026
Marijuana MSOs surge on report Trump set to formally reclassify cannabis
Seeking Alpha News (Wed, 22-Apr 12:39 PM ET)
PRNewswire (Thu, 12-Feb 4:05 PM ET)
Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand
PRNewswire (Wed, 11-Feb 7:00 AM ET)
Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program
PRNewswire (Wed, 4-Feb 7:00 AM ET)
Aurora Cannabis Announces Fiscal 2026 Third Quarter Results
PRNewswire (Wed, 4-Feb 7:00 AM ET)
Aurora Launches New European Websites, Showcasing Science-Backed Cannabis Leadership
PRNewswire (Tue, 3-Feb 7:00 AM ET)
Aurora Expands Medical Cannabis Reach in Germany With Daily Special Brand Launch
Market Chameleon (Thu, 18-Dec 6:14 AM ET)
Market Chameleon (Thu, 18-Dec 2:58 AM ET)
Market Chameleon (Fri, 12-Dec 5:33 AM ET)
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of April 22, 2026, ACB stock price climbed to $3.80 with 8,821,312 million shares trading.
ACB has a beta of 1.41, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.10 to the broad based SPY ETF.
ACB has a market cap of $224.68 million. This is considered a Small Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $68 million in Revenue and $.02 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.17.
In the last 3 years, ACB traded as high as $11.50 and as low as $2.84.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ, YOLO, DFIC, NPFE.
ACB has underperformed the market in the last year with a return of -9.5%, while the SPY ETF gained +39.8%. In the last 3 month period, ACB fell short of the market, returning -10.4%, while SPY returned +4.0%. However, in the most recent 2 weeks ACB has outperformed the stock market by returning +12.8%, while SPY returned +7.9%.
ACB support price is $3.45 and resistance is $3.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB shares will trade within this expected range on the day.